Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist

Keith E. Friend M.D. 1 , Robert Radinsky Ph.D. 1 and Ian E. McCutcheon M.D., F.R.C.S.(C) 1
View More View Less
  • 1 Section of Endocrine Neoplasia and Hormonal Disorders, and Departments of Cancer Biology and Neurosurgery, University of Texas M. D. Anderson Cancer Center, Houston, Texas
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object. This study was undertaken to explore the effects of growth hormone (GH) and the GH-stimulated peptide insulin-like growth factor—1 (IGF-1) on the growth rate of meningiomas.

Methods. Polymerase chain reaction and ribonuclease protection assays were used to demonstrate that GH receptor messenger RNA was present in all 14 meningioma specimens studied, regardless of tumor grade. Both wild type (GHRwt) and a previously described exon 3 deletion isoform (GHRd3) of the GH receptor were identified in individual tumor specimens. The importance of the GH receptor was assessed using a GH receptor antagonist (B2036). Blockade of the GH receptor with B2036 reduced serum-induced DNA synthesis, as measured by thymidine incorporation, by 8 to 33% (mean 20%) in primary meningioma cultures. Tumors that expressed the GHRwt and GHRd3 isoforms, or a combination of the two, were all responsive to antagonist treatment. The importance of IGF-1 in stimulating meningioma cell growth was also assessed. It was found that IGF-1 increased thymidine incorporation in primary meningioma cultures in a dose-dependent manner: 1 ng/ml, 5 ng/ml, and 10 ng/ml resulted in increases in thymidine incorporation of 21%, 43%, and 176%, respectively, over baseline values.

Conclusions. In these studies the authors demonstrate that activation of the GH/IGF-1 axis significantly increases the growth rate of meningiomas. Blockade of the GH receptor on tumor cells inhibited tumor growth. If these findings are confirmed in animal studies, agents that downregulate the GH/IGF-1 axis might represent a potential adjuvant therapy in the management of patients with meningioma.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Ian E. McCutcheon, M.D., University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 64, Houston, Texas 77030. email: imccutch@notes.mdacc.tmc.edu.
  • 1.

    Antoniades HN, , Galanopoulos T, & Neville-Golden J, et al: Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas: in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50:215222, 1992 Antoniades HN, Galanopoulos T, Neville-Golden J, et al: Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas: in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50:215–222, 1992

    • Search Google Scholar
    • Export Citation
  • 2.

    Bass SH, , Mulkerrin MG, & Wells JA: A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci USA 88:44984502, 1991 Bass SH, Mulkerrin MG, Wells JA: A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci USA 88:4498–4502, 1991

    • Search Google Scholar
    • Export Citation
  • 3.

    Bunick EM, , Mills LC, & Rose LI: Association of acromegaly and meningiomas. JAMA 240:12671268, 1978 Bunick EM, Mills LC, Rose LI: Association of acromegaly and meningiomas. JAMA 240:1267–1268, 1978

    • Search Google Scholar
    • Export Citation
  • 4.

    Chen XZ, , Shafer AW, & Yun JS, et al: Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice. Mol Endocrinol 6:598606, 1992 Chen XZ, Shafer AW, Yun JS, et al: Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice. Mol Endocrinol 6:598–606, 1992

    • Search Google Scholar
    • Export Citation
  • 5.

    Dunn SE, , Hardman RA, & Kari FW, et al: Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 57:26872693, 1997 Dunn SE, Hardman RA, Kari FW, et al: Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res 57:2687–2693, 1997

    • Search Google Scholar
    • Export Citation
  • 6.

    Esposito N, , Paterlini P, & Kelly PA, et al: Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma. Mol Cell Endocrinol 103:1320, 1994 Esposito N, Paterlini P, Kelly PA, et al: Expression of two isoforms of the human growth hormone receptor in normal liver and hepatocarcinoma. Mol Cell Endocrinol 103:13–20, 1994

    • Search Google Scholar
    • Export Citation
  • 7.

    Friend KE, , Ang LW, & Shupnik MA: Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci USA 92:43674371, 1995 Friend KE, Ang LW, Shupnik MA: Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary. Proc Natl Acad Sci USA 92:4367–4371, 1995

    • Search Google Scholar
    • Export Citation
  • 8.

    Friend KE, , Chiou YK, & Lopes MBS, et al: Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 78:14971504, 1994 Friend KE, Chiou YK, Lopes MBS, et al: Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 78:1497–1504, 1994

    • Search Google Scholar
    • Export Citation
  • 9.

    Glick RP, , Gettleman R, & Patel K, et al: Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. Neurosurgery 24:791797, 1989 Glick RP, Gettleman R, Patel K, et al: Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects. Neurosurgery 24:791–797, 1989

    • Search Google Scholar
    • Export Citation
  • 10.

    Godowski PJ, , Leung DW, & Meacham LR, et al: Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 86:80838087, 1989 Godowski PJ, Leung DW, Meacham LR, et al: Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 86:8083–8087, 1989

    • Search Google Scholar
    • Export Citation
  • 11.

    Goldberg MB, , Sheline GE, & Malamud N: Malignant intracranial neoplasms following radiation therapy for acromegaly. Radiology 80:465470, 1963 Goldberg MB, Sheline GE, Malamud N: Malignant intracranial neoplasms following radiation therapy for acromegaly. Radiology 80:465–470, 1963

    • Search Google Scholar
    • Export Citation
  • 12.

    Irsy G, , Góth M, & Slovik F, et al: Growth hormone producing pituitary adenoma and meningioma. Zentralbl Neurochir 46:337343, 1985 Irsy G, Góth M, Slovik F, et al: Growth hormone producing pituitary adenoma and meningioma. Zentralbl Neurochir 46:337–343, 1985

    • Search Google Scholar
    • Export Citation
  • 13.

    Ituarte EA, , Petrini J, & Hershman JM: Acromegaly and colon cancer. Ann Intern Med 101:627628, 1984 Ituarte EA, Petrini J, Hershman JM: Acromegaly and colon cancer. Ann Intern Med 101:627–628, 1984

    • Search Google Scholar
    • Export Citation
  • 14.

    Jensen RL, , Lee YS, & Guijrati M, et al: Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: part II—additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery 37:937947, 1995 Jensen RL, Lee YS, Guijrati M, et al: Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: part II—additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery 37:937–947, 1995

    • Search Google Scholar
    • Export Citation
  • 15.

    Jensen RL, , Origitano TC, & Lee YS, et al: In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36:365374, 1995 Jensen RL, Origitano TC, Lee YS, et al: In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery 36:365–374, 1995

    • Search Google Scholar
    • Export Citation
  • 16.

    Karey KP, & Sirbasku DA: Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res 48:40834092, 1988 Karey KP, Sirbasku DA: Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res 48:4083–4092, 1988

    • Search Google Scholar
    • Export Citation
  • 17.

    Koper JW, , Zwarthoff EC, & Hagemeijer A, et al: Inhibitation of the growth of cultured human meningioma cells by recombinant interferon-α. Eur J Cancer 27:416419, 1991 Koper JW, Zwarthoff EC, Hagemeijer A, et al: Inhibitation of the growth of cultured human meningioma cells by recombinant interferon-α. Eur J Cancer 27:416–419, 1991

    • Search Google Scholar
    • Export Citation
  • 18.

    Kurihara M, , Tokunaga Y, & Tsutsumi K, et al: Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma. J Neurosurg 71:538544, 1989 Kurihara M, Tokunaga Y, Tsutsumi K, et al: Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma. J Neurosurg 71:538–544, 1989

    • Search Google Scholar
    • Export Citation
  • 19.

    Kyritsis AP: Chemotherapy for meningiomas. J Neurooncol 29:269272, 1996 Kyritsis AP: Chemotherapy for meningiomas. J Neurooncol 29:269–272, 1996

    • Search Google Scholar
    • Export Citation
  • 20.

    Lawrence JH, , Tobias CA, & Linfoot JA: Successful treatment of acromegaly: metabolic and clinical studies in 145 patients. J Clin Endocrinol Metab 31:180198, 1970 Lawrence JH, Tobias CA, Linfoot JA: Successful treatment of acromegaly: metabolic and clinical studies in 145 patients. J Clin Endocrinol Metab 31:180–198, 1970

    • Search Google Scholar
    • Export Citation
  • 21.

    Lee WH: Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27:389396, 1990 Lee WH: Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27:389–396, 1990

    • Search Google Scholar
    • Export Citation
  • 22.

    Nabarro JDN: Acromegaly. Clin Endocrinol 26:481512, 1987 Nabarro JDN: Acromegaly. Clin Endocrinol 26:481–512, 1987

  • 23.

    Ortego J, , Vega B, & Sampedro J, et al: Neoplastic colonic polyps in acromegaly. Horm Metab Res 26:609610, 1994 Ortego J, Vega B, Sampedro J, et al: Neoplastic colonic polyps in acromegaly. Horm Metab Res 26:609–610, 1994

    • Search Google Scholar
    • Export Citation
  • 24.

    Pettaway CA, , Pathak S, & Greene G, et al: Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2:16271636, 1996 Pettaway CA, Pathak S, Greene G, et al: Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2:1627–1636, 1996

    • Search Google Scholar
    • Export Citation
  • 25.

    Radinsky R, , Fidler IJ, & Price JE, et al: Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 9:18771883, 1994 Radinsky R, Fidler IJ, Price JE, et al: Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 9:1877–1883, 1994

    • Search Google Scholar
    • Export Citation
  • 26.

    Radinsky R, , Risin S, & Fan D, et al: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1:1931, 1995 Radinsky R, Risin S, Fan D, et al: Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1:19–31, 1995

    • Search Google Scholar
    • Export Citation
  • 27.

    Ron E, , Gridley G, & Hrubec Z, et al: Acromegaly and gastrointestinal cancer. Cancer 68:16731677, 1991 Ron E, Gridley G, Hrubec Z, et al: Acromegaly and gastrointestinal cancer. Cancer 68:1673–1677, 1991

    • Search Google Scholar
    • Export Citation
  • 28.

    Schrell UMH, , Rittig MG, & Anders M, et al: Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 86:845852, 1997 Schrell UMH, Rittig MG, Anders M, et al: Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway. J Neurosurg 86:845–852, 1997

    • Search Google Scholar
    • Export Citation
  • 29.

    Schrell UMH, , Rittig MG, & Anders M, et al: Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 86:840844, 1997 Schrell UMH, Rittig MG, Anders M, et al: Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea. J Neurosurg 86:840–844, 1997

    • Search Google Scholar
    • Export Citation
  • 30.

    Sobrier ML, , Duquesnoy P, & Duriez B, et al: Expression and binding properties of two isoforms of the human growth hormone receptor. FEBS Lett 319:1620, 1993 Sobrier ML, Duquesnoy P, Duriez B, et al: Expression and binding properties of two isoforms of the human growth hormone receptor. FEBS Lett 319:16–20, 1993

    • Search Google Scholar
    • Export Citation
  • 31.

    Stallings-Mann ML, , Ludwiczak RL, & Klinger KW, et al: Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Proc Natl Acad Sci USA 93:1239412399, 1996 Stallings-Mann ML, Ludwiczak RL, Klinger KW, et al: Alternative splicing of exon 3 of the human growth hormone receptor is the result of an unusual genetic polymorphism. Proc Natl Acad Sci USA 93:12394–12399, 1996

    • Search Google Scholar
    • Export Citation
  • 32.

    Urbanek M, , MacLeod JN, & Cooke NE, et al: Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript. Mol Endocrinol 6:279287, 1992 Urbanek M, MacLeod JN, Cooke NE, et al: Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor gene transcript. Mol Endocrinol 6:279–287, 1992

    • Search Google Scholar
    • Export Citation
  • 33.

    Urbanek M, , Russell JE, & Cooke NE, et al: Functional characterization of the alternatively spliced, placental human growth hormone receptor. J Biol Chem 268:1902519032, 1993 Urbanek M, Russell JE, Cooke NE, et al: Functional characterization of the alternatively spliced, placental human growth hormone receptor. J Biol Chem 268:19025–19032, 1993

    • Search Google Scholar
    • Export Citation
  • 34.

    Yazaki T, , Takamiya Y, & Costello PC, et al: Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470. J Neurooncol 23:2329, 1995 Yazaki T, Takamiya Y, Costello PC, et al: Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470. J Neurooncol 23:23–29, 1995

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 478 150 12
Full Text Views 193 6 0
PDF Downloads 116 7 1
EPUB Downloads 0 0 0